Search for: "C Lillie" Results 141 - 160 of 441
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 May 2015, 4:00 am by Administrator
Eli Lily and Company, 2015 ONCA 305 [55] This is not a bilateral context where Apotex is the only party that has been wronged by Lilly. [read post]
28 Mar 2010, 5:07 pm
Chantal writes to inform him as follows: "The almost endless series of olanzapine cases (inter alia Eli Lilly patent EP 0 454 436) has now produced an interesting sequel in the Netherlands. [read post]
26 Oct 2011, 7:59 am by Joe Consumer
  Zyprexa, you may know, has serious side-effects that can lead to  diabetes and its manufacturer, Eli Lilly, has been sued by tens of thousands of ill Zyprexa users, telling salespeople to downplay these side effects. [read post]
23 Jan 2009, 4:00 am
While I was waiting for the Ledbetter vote on C-SPAN 2 last night (come on, you KNOW I'm all geeky like that!) [read post]
28 Oct 2017, 8:57 am by Anders Valentin
Citing CJEU case law (C-322/10 ”Medeva” and C-493/12 ”Eli Lilly”) as well as the DKPTO Guide Lines on SPCs – which state that a combination product consisting in the two active ingredients A and B are considered as protected, when A and B are stated in a patent claim – the Court concluded that ”Emtricitabin does not appear in the wording of claim 27, just as emtricitabin is not described by way of chemical name or structural… [read post]
10 Oct 2010, 6:21 am
Also brought within the IPO’s corral is the decision in Dr Reddy’s Laboratories (UK) Ltd v Eli Lilly & Co Ltd [2010] RPC 8 (noted by the IPKat here), in which the Court of Appeal delved into the murky depths of selection invention – asking, in the process, where a wise man would hide a leaf… The sections on supplementary protection certificates has also been updated in light of the decisions of the High Court in Yeda Research and Development Company Ltd v… [read post]
20 Nov 2010, 6:11 pm by Mark Zamora
It was claimed that Propoxyphene had no or little contribution to efficacy of reduction of acute pain.Darvon was initially developed by Eli-Lilly and now marketed by two companies--Xanodyne Pharmaceuticals of Kentucky and Qualitest/Vintage Pharmaceuticals of Alabama--was first approved for use in the United States in 1957. [read post]
29 Feb 2024, 5:17 pm by Kurt R. Karst
§ 156(c); and (2) why the PTE application for the ‘929 patent should remain under consideration despite Lilly’s express written request of withdrawal (revocation) of BLA-761038 and waiver of the opportunity for a hearing. [read post]
31 Aug 2010, 10:01 pm by Kelly
(FDA Law Blog) US: District Court N D Illinois construes claims re method of treating kidney disease: Bone Care v Pentech Pharma (Chicago IP Litigation Blog) Products Angiomax (Bivalirudin) – US: Medicines Company files patent infringement complaint against Hospira in response to Para IV challenge (Patent Docs) Aranesp (Darbepoetin) – EU: ECJ to rule on Aranesp Thursday 2 Sept: Case C-66/09 Kirin Amgen (The SPC Blog) Baraclude (Entecavir) – India: Natco and Zydus Cadila… [read post]
7 Mar 2016, 1:55 am
* Of stripes, positions, and shoes: CJEU's decision in Adidas three-stripe caseThis is about the Court of Justice of the European Union's (CJEU) decision in Shoe Branding Europe BVBA v Adidas and OHIM [Case C‑396/15 P], another trade mark case upon parallel stripes and shoes. [read post]
10 Aug 2017, 3:41 pm
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
3 Mar 2023, 12:01 am by Gene Takagi
Today, Eli Lilly did that,” Biden said in a statement. [read post]
22 May 2017, 1:00 am by Matrix Legal Support Service
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
24 Jul 2011, 9:44 am by Blog Editorial
Human Genome Sciences Inc v Eli Lilly and Company, heard 18 – 20 July 2011. [read post]